Resveratrol analogs and prodrugs differently affect the survival of breast cancer cells impairing estrogen/estrogen receptor /neuroglobin pathway

HIGHLIGHTS

  • who: Emiliano Montalesi and colleagues from the Department of Science, University Roma Tre, Vle Marconi, , Rome, Italy have published the Article: Resveratrol Analogs and Prodrugs Differently Affect the Survival of Breast Cancer Cells Impairing Estrogen/Estrogen Receptor /Neuroglobin Pathway, in the Journal: (JOURNAL) of 16/Dec/2022
  • what: In the present study, four different RSV analogs were developed and their effects on ERu03b1/NGB pathway were compared with RSV-conjugated gold nanospheres as a prodrug to evaluate if RSV derivatives maintain breast cancer cell susceptibility to the chemotherapeutic drug paclitaxel as the non-conjugated compound . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?